Bodal Chemicals 미래 성장

Future 기준 확인 4/6

Bodal Chemicals (는) 각각 연간 92.5% 및 15.8% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 93.4% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 6.9% 로 예상됩니다.

주요 정보

92.5%

수익 성장률

93.4%

EPS 성장률

Chemicals 수익 성장	23.3%
매출 성장률	15.8%
향후 자기자본 수익률	6.9%
애널리스트 커버리지	Low
마지막 업데이트	29 Nov 2024

최근 미래 성장 업데이트

Recent updates

We Think Shareholders May Want To Consider A Review Of Bodal Chemicals Limited's (NSE:BODALCHEM) CEO Compensation Package

Sep 18

When Should You Buy Bodal Chemicals Limited (NSE:BODALCHEM)?

Apr 04

Need To Know: This Analyst Just Made A Substantial Cut To Their Bodal Chemicals Limited (NSE:BODALCHEM) Estimates

Aug 18

Increases to Bodal Chemicals Limited's (NSE:BODALCHEM) CEO Compensation Might Cool off for now

Sep 20

Bodal Chemicals Limited's (NSE:BODALCHEM) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?

Mar 21

These 4 Measures Indicate That Bodal Chemicals (NSE:BODALCHEM) Is Using Debt Extensively

Mar 06

How Is Bodal Chemicals' (NSE:BODALCHEM) CEO Compensated?

Feb 19

Is Bodal Chemicals Limited (NSE:BODALCHEM) A Great Dividend Stock?

Feb 06

What Percentage Of Bodal Chemicals Limited (NSE:BODALCHEM) Shares Do Insiders Own?

Jan 22

Would Shareholders Who Purchased Bodal Chemicals' (NSE:BODALCHEM) Stock Three Years Be Happy With The Share price Today?

Jan 06

Are Insiders Buying Bodal Chemicals Limited (NSE:BODALCHEM) Stock?

Dec 22

Bodal Chemicals Limited (NSE:BODALCHEM) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?

Dec 07

Here's Why Bodal Chemicals (NSE:BODALCHEM) Has A Meaningful Debt Burden

Nov 22

Is Bodal Chemicals Limited (NSE:BODALCHEM) A Strong Dividend Stock?

Nov 07

Is Bodal Chemicals (NSE:BODALCHEM) Likely To Turn Things Around?

Oct 13

What You Need To Know About Bodal Chemicals Limited's (NSE:BODALCHEM) Investor Composition

Sep 25

Who Has Been Buying Bodal Chemicals Limited (NSE:BODALCHEM) Shares?

Sep 09

If You Had Bought Bodal Chemicals (NSE:BODALCHEM) Stock Five Years Ago, You Could Pocket A 144% Gain Today

Aug 25

Bodal Chemicals (NSE:BODALCHEM) Has A Somewhat Strained Balance Sheet

Aug 10

What Did Bodal Chemicals' (NSE:BODALCHEM) CEO Take Home Last Year?

Aug 10

수익 및 매출 성장 예측

NSEI:BODALCHEM - 애널리스트의 미래 추정치 및 과거 재무 데이터 (INR Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
3/31/2027	22,803	934	730	1,721	1
3/31/2026	20,506	570	477	1,630	2
3/31/2025	16,669	126	620	1,435	2
9/30/2024	15,827	16	937	2,131	N/A
6/30/2024	14,841	31	N/A	N/A	N/A
3/31/2024	13,946	65	-407	2,042	N/A
12/31/2023	13,906	72	N/A	N/A	N/A
9/30/2023	13,821	87	-348	2,192	N/A
6/30/2023	14,440	177	N/A	N/A	N/A
3/31/2023	15,743	380	-479	2,899	N/A
12/31/2022	17,678	676	N/A	N/A	N/A
9/30/2022	20,138	896	-2,157	1,101	N/A
6/30/2022	20,878	1,030	N/A	N/A	N/A
3/31/2022	20,553	1,042	-1,726	-135	N/A
12/31/2021	18,861	1,004	N/A	N/A	N/A
9/30/2021	16,904	1,052	-2,713	-355	N/A
6/30/2021	15,304	916	N/A	N/A	N/A
3/31/2021	12,264	420	-1,911	-130	N/A
12/31/2020	11,622	418	N/A	N/A	N/A
9/30/2020	11,224	297	677	1,198	N/A
6/30/2020	11,204	406	N/A	N/A	N/A
3/31/2020	13,748	872	-425	96	N/A
12/31/2019	13,506	941	N/A	N/A	N/A
9/30/2019	13,586	1,091	-1,367	115	N/A
6/30/2019	14,441	1,323	N/A	N/A	N/A
3/31/2019	14,235	1,432	377	1,860	N/A
12/31/2018	13,725	1,528	N/A	N/A	N/A
9/30/2018	13,454	1,527	N/A	N/A	N/A
6/30/2018	12,083	1,321	N/A	N/A	N/A
3/31/2018	11,422	1,226	N/A	71	N/A
3/31/2017	12,344	1,329	N/A	1,036	N/A
3/31/2016	9,078	860	N/A	1,312	N/A
3/31/2015	10,443	918	N/A	1,977	N/A
3/31/2014	9,496	302	N/A	492	N/A

애널리스트 미래 성장 예측

수입 대 저축률: BODALCHEM 의 연간 예상 수익 증가율( 92.5% )이 saving rate( 6.7% 보다 높습니다. ).

수익 vs 시장: BODALCHEM 의 연간 수익( 92.5% ) Indian 시장( 17.8% 보다 빠르게 성장할 것으로 예상됩니다. 17.8% 연간).

고성장 수익: BODALCHEM 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.

수익 대 시장: BODALCHEM 의 수익(연간 15.8% ) Indian 시장( 10.4% 보다 빠르게 성장할 것으로 예상됩니다. 10.4% 연간).

고성장 수익: BODALCHEM 의 수익(연간 15.8% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: BODALCHEM 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 6.9 %).

성장 기업 발견

기업 분석 및 재무 데이터 현황

데이터	마지막 업데이트(UTC 시간)
기업 분석	2025/01/23 01:53
장 마감 주가	2025/01/23 00:00
수익	2024/09/30
연간 수익	2024/03/31

데이터 소스

기업 분석에 사용된 데이터는 S&P Global Market Intelligence LLC의 데이터입니다. 이 보고서를 생성하기 위해 분석 모델에 사용된 데이터는 다음과 같습니다. 데이터는 정규화되어 있으므로 소스가 제공되기까지 지연이 발생할 수 있습니다.

패키지	데이터	기간	미국 소스 예시 ^*
회사 재무	10년	손익 계산서 현금 흐름표 대차 대조표	SEC 양식 10-K SEC 양식 10-Q
애널리스트 컨센서스 추정치	+3년	재무 예측 애널리스트 목표가	애널리스트 연구 보고서 Blue Matrix
시장 가격	30년	주식 가격 배당금, 분할 및 액션	ICE 시장 데이터 SEC 양식 S-1
소유권	10년	최대 주주 내부자 거래	SEC 양식 4 SEC 양식 13D
관리	10년	리더십 팀 이사회	SEC 양식 10-K SEC 양식 DEF 14A
주요 개발 사항	10년	회사 공지 사항	SEC 양식 8-K

* 미국 증권의 경우, 미국 외 지역의 규제 양식 및 출처가 사용된 예입니다.

명시되지 않는 한 모든 재무 데이터는 1년을 기준으로 하지만 분기별로 업데이트됩니다. 이를 후행 12개월(TTM) 또는 최근 12개월(LTM) 데이터라고 합니다. 여기에서 자세히 알아보세요.

분석 모델 및 눈송이

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 Github 페이지에서 확인할 수 있으며, 보고서 사용 방법에 대한 가이드와 튜토리얼도 유튜브에서 확인할 수 있습니다.

Simply 월스트리트 분석 모델을 설계하고 구축한 세계적인 수준의 팀에 대해 알아보세요.

산업 및 부문 메트릭

업계 및 섹션 지표는 Simply Wall St에서 6시간마다 계산되며, 자세한 내용은 확인할 수 있습니다.

애널리스트 출처

Bodal Chemicals Limited 5 애널리스트 중 2 애널리스트가 보고서의 입력 자료로 사용된 매출 또는 수익 추정치를 제출했습니다. 애널리스트의 제출 자료는 하루 종일 업데이트됩니다.

분석가	교육기관
Nikhil Shetty	BP Wealth Management Private Limited
Anil Burra	FirstCall Research
Chirag Shah	ICICIdirect.com

Bodal Chemicals 미래 성장

Future 기준 확인 4/6

주요 정보

최근 미래 성장 업데이트

Price target increased by 7.7% to ₹90.50

Price target increased by 11% to ₹90.00

Price target decreased by 40% to ₹85.00

Price target increased to ₹103

Price target lowered to ₹79.00

Recent updates

Now 22% undervalued after recent price drop

New minor risk - Market cap size

Now 21% undervalued after recent price drop

Second quarter 2025 earnings released: ₹0.02 loss per share (vs ₹0.09 profit in 2Q 2024)

Bodal Chemicals Limited to Report Q2, 2025 Results on Nov 14, 2024

We Think Shareholders May Want To Consider A Review Of Bodal Chemicals Limited's (NSE:BODALCHEM) CEO Compensation Package

Insufficient new directors

Bodal Chemicals Limited, Annual General Meeting, Sep 24, 2024

Bodal Chemicals Limited to Report Q1, 2025 Results on Aug 14, 2024

Bodal Chemicals Limited Decides to Permanently Stop Production Activities at the Manufacturing Facilities of Unit-1, Unit3 and Unit-4 Located at Vatva Gidc, Ahmedabad, Gujarat

Bodal Chemicals Limited to Report Fiscal Year 2024 Results on May 24, 2024

Now 21% undervalued after recent price drop

Now 20% undervalued after recent price drop

When Should You Buy Bodal Chemicals Limited (NSE:BODALCHEM)?

Now 24% undervalued

Bodal Chemicals Limited announced that it expects to receive INR 214 million in funding

Insufficient new directors

Now 20% undervalued

Price target increased by 7.7% to ₹90.50

Third quarter 2024 earnings released: EPS: ₹0.08 (vs ₹0.19 in 3Q 2023)

Bodal Chemicals Limited to Report Q3, 2024 Results on Feb 13, 2024

Second quarter 2024 earnings released: EPS: ₹0.09 (vs ₹0.78 in 2Q 2023)

Bodal Chemicals Limited to Report Q2, 2024 Results on Nov 06, 2023

Bodal Chemicals Limited Declares Dividend for the Fiscal Year 2023

Upcoming dividend of ₹0.10 per share at 0.1% yield

Bodal Chemicals Limited Proposes Final Dividend for the Financial Year 2022-23

Need To Know: This Analyst Just Made A Substantial Cut To Their Bodal Chemicals Limited (NSE:BODALCHEM) Estimates

Price target increased by 11% to ₹90.00

First quarter 2024 earnings released: EPS: ₹0.18 (vs ₹1.95 in 1Q 2023)

Bodal Chemicals Limited, Annual General Meeting, Sep 28, 2023

Bodal Chemicals Limited to Report Q1, 2024 Results on Aug 11, 2023

Investor sentiment improves as stock rises 16%

Full year 2023 earnings released: EPS: ₹3.03 (vs ₹8.79 in FY 2022)

Bodal Chemicals Limited Recommends Final Dividend for the Financial Year 2022-23

Bodal Chemicals Limited to Report Q4, 2023 Results on May 30, 2023

Price target decreased by 40% to ₹85.00

Bodal Chemicals Limited Decides to Dismantle Manufacturing Facilities of Unit- 2

Bodal Chemicals Limited to Report Q3, 2023 Results on Feb 14, 2023

Bodal Chemicals Limited Announces Board Changes

Second quarter 2023 earnings released: EPS: ₹0.78 (vs ₹2.06 in 2Q 2022)

Bodal Chemicals Limited Approves Dividend for the Financial Year 2021-22

Increases to Bodal Chemicals Limited's (NSE:BODALCHEM) CEO Compensation Might Cool off for now

Upcoming dividend of ₹0.80 per share

Bodal Chemicals' (NSE:BODALCHEM) Dividend Will Be ₹0.80

Bodal Chemicals Limited Proposes Dividend for the Financial Year 2021-22

First quarter 2023 earnings released: EPS: ₹1.95 (vs ₹2.44 in 1Q 2022)

Bodal Chemicals Limited to Report Q1, 2023 Results on Aug 09, 2022

Is Bodal Chemicals (NSE:BODALCHEM) A Risky Investment?

Full year 2022 earnings released: EPS: ₹8.79 (vs ₹3.43 in FY 2021)

Bodal Chemicals Limited Recommends Final Dividend for the Financial Year 2021-22

Bodal Chemicals Limited (BSE:524370) completed the acquisition of remaining 20% stake in Sener Boya Kimya Tekstil Anonim Sirketi.

Third quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat

Bodal Chemicals Limited (BSE:524370) agreed to acquire remaining 20% stake in Sener Boya Kimya Tekstil Anonim Sirketi for INR 320 million.

Bodal Chemicals Limited to Report Q3, 2022 Results on Feb 11, 2022

Is Bodal Chemicals (NSE:BODALCHEM) A Risky Investment?

Investor sentiment improved over the past week

Upcoming dividend of ₹0.80 per share

First quarter 2022 earnings released: EPS ₹2.44 (vs ₹1.60 loss in 1Q 2021)

Bodal Chemicals (NSE:BODALCHEM) Has A Somewhat Strained Balance Sheet

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS ₹3.25 (vs ₹7.16 in FY 2020)

Price target increased to ₹103

Should You Investigate Bodal Chemicals Limited (NSE:BODALCHEM) At ₹95.80?

Bodal Chemicals Limited's (NSE:BODALCHEM) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?

These 4 Measures Indicate That Bodal Chemicals (NSE:BODALCHEM) Is Using Debt Extensively

Investor sentiment improved over the past week

New 90-day low: ₹68.50

How Is Bodal Chemicals' (NSE:BODALCHEM) CEO Compensated?

Third quarter 2021 earnings released: EPS ₹2.16 (vs ₹1.05 in 3Q 2020)

Bodal Chemicals Limited (BSE:524370) entered into business transfer agreement to acquire Siel Chemical Complex from Mawana Sugars Limited (BSE:523371) for INR 1370 million.